Clinical Trial Update: Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA) [Phase 3]

View source ↗

Summary

Phase 3 trial CAMELIA compared early versus delayed initiation of antiretroviral therapy in HIV-infected patients with tuberculosis; the study has completed enr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• antiretroviral therapy (ART) (antiretroviral therapy)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infection, Tuberculosis | Phase 3 | Status: COMPLETED